KIR2DS5 in the presence of HLA-C C2 protects against endometriosis by Izabela Nowak et al.
ORIGINAL PAPER
KIR2DS5 in the presence of HLA-C C2 protects
against endometriosis
Izabela Nowak & Rafał Płoski & Ewa Barcz & Piotr Dziunycz & Paweł Kamiński &
Grażyna Kostrzewa & Łukasz Milewski & Piotr I. Roszkowski & David Senitzer &
Jacek Malejczyk & Piotr Kuśnierczyk
Received: 15 December 2014 /Accepted: 5 February 2015 /Published online: 1 March 2015
# The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract Endometriosis is defined as the presence of func-
tional endometrial tissue outside the uterine cavity. Several
hypotheses have attempted to explain the etiology and patho-
genesis of endometriosis. Recently, it has been suggested that
a defect of the natural killer (NK) activity in the recognition
and lysis of endometrial cells is one of the crucial points in the
development of this disease. Natural killer cells can express
killer immunoglobulin-like receptors (KIR), which recognize
class I human leukocyte antigens on target cells. We asked
whether polymorphisms in KIR, HLA-C, and HLA-B genes
are risk factors for endometriosis. We tested 153 women with
endometriosis diagnosed on the basis of laparoscopic and
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histological examination, and 213 control healthy women,
who gave birth to at least one child. The frequency of KIR
genes in patients was similar to that in controls except for
KIR2DS5, which exerted a protective effect only in HLA-C
C2-positive individuals.Moreover,KIR2DS5-positive women
with endometriosis had 13 times lower chance that the disease
would occupy the peritoneum than KIR2DS5- and
KIR2DS4del-negative ones (OR=0.077, P=0.0061). Similar-
ly, KIR2DS4del-positive endometriotic persons had 11 times
lower chance for peritoneal disease (OR=0.094, P<0.001).
Negative linkage disequilibrium between KIR2DS5 and
KIR2DS4del indicates that these genes are mutually exclusive.
Our data suggest that KIR2DS5 may be associated with pro-
tection from endometriosis, whereas KIR2DS4del seems to be
associated with higher disease stages, possibly by exclusion of
protective KIR2DS5.
Keywords Endometriosis . Killer cell immunoglobulin-like
receptor . Human leukocyte antigen . Linkage
disequilibrium
Introduction
Endometriosis is a common gynecological disease, which af-
fects approximately from 2 to 10 % of women in reproductive
age. Patients with endometriosis suffer from pelvic pain,
dyspareunia, dysuria, dysmenorrhea, and they constitute
about 50 % of infertile women (Dunselman et al. 2014). En-
dometriosis is defined as the presence of functional endome-
trial tissue outside the uterine cavity, mostly in the pelvic
peritoneum, ovaries, and rectovaginal septum (Burney and
Giudice 2012; Gupta et al. 2008; The Practice Committee of
the American Society for Reproductive Medicine 2012). Sev-
eral hypotheses have attempted to explain the etiology and
pathogenesis of endometriosis, mainly Sampson’s theory of
retrograde menstruation of the endometrial tissue through the
fallopian tubes and into the peritoneal cavity, and its subse-
quent implantation (Sampson 1927). It has been suggested
that a defect of the natural killer (NK) activity in the recogni-
tion and lysis of these implanted endometrial cells may be one
of the crucial points in the initiation and progression of endo-
metriosis (Berkkanoglu and Arici 2003).
Natural killer cells can express killer immunoglobulin-like
receptors (KIR), which recognize class I human leukocyte
antigens (HLA) on target cells and may either stimulate or
inhibit NK cell activity. KIR receptors occur as two or three
extracellular immunoglobulin-like domain molecules with a
long (L) or short (S) cytoplasmic tail. KIR2DL/KIR3DL has
inhibitory function in contrast to KIR2DS/3DSwith activating
function. KIR genes exhibit extensive haplotypic and allelic
polymorphism. Individuals differ in both the number and kind
(activating vs. inhibitory) of KIR genes (Middleton and
Gonzelez 2010; Falco et al. 2013; Kulkarni et al. 2008).
HLA-C molecules can be divided into two groups, HLA-C
C1 and C2, according to the amino acid present at position 80
of the molecule. All HLA-C molecules with asparagine at
position 80 belong to the HLA-C C1 group, and are recog-
nized by KIR2DL2/2DS2 and KIR2DL3, whereas those with
lysine in this position belong to the HLA-C C2 group and
constitute ligands for KIR2DL1/2DS1. However, KIR2DL2/
2DL3 may also bind to some C2 molecules. KIR2DS4 binds
HLA-A11 and some C1 and C2 molecules (Graef et al. 2009).
Finally, KIR3DL1 has specificity for HLA-Bw4 epitope
(Middleton and Gonzelez 2010; Falco et al. 2013; Kulkarni
et al. 2008).
KIR and HLA polymorphism affects NK cell reactivity and
susceptibility to various diseases (Kulkarni et al. 2008). The
aim of our study was to find an association of KIR genes and
their HLA ligands with susceptibility to endometriosis in Pol-
ish women. To our knowledge, this is the first study in females
emphasizing the role of KIR2DS5 and KIR2DS4 deletion var-
iant (KIR2DS4del) in clinical stages of endometriosis.
Materials and methods
Study design
One hundred and fifty-three Polish patients with endometri-
osis (age range, 20–58 years; mean±S.D., 33.7±8.0 years)
diagnosed at the First and Second Department of Obstetrics
and Gynecology, Medical University of Warsaw for pelvic
pain, dysmenorrhea, and/or infertility were included in the
study. Patients were classified according to the revised Amer-
ican Fertility Society criteria (American Fertility Society
1985) and both laparoscopic and histopathological examina-
tions. All patients were categorized into four subgroups: I–
II—minimal and mild stages, III—moderate, and IV—severe
stages. Among them, 98 (64.1 %) patients manifested ovarian
endometriosis, 43 (28.1 %) patients had ovarian and peritone-
al endometriosis, and 12 (7.8 %) patients had only peritoneal
endometriosis.
The control group consisted of 213 women. Among this
group, 96 women were anonymous adults from paternity test-
ing, who gave birth to at least one child, but there was no
information on the disease status as they were anonymous.
The remaining 117 women (age range, 23–68 years; mean
age±S.D., 31.37±6.36) reported having at least two babies
with the same partner and no gynecological, endocrinological,
or immunological disorders (described earlier by Nowak et al.
2009). Experimental protocols were approved by the Local
Ethics Committee and all patients gave their informed consent
to the study.
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DNA preparation and genotyping
Genomic DNA was isolated from venous blood using the
salting out method or using an Invisorb Spin Blood Midi Kit
(Invitek, Berlin, Germany) following the manufacturer’s in-
structions. KIR genotyping was described previously by
Nowak et al. (2009) and Sun et al. (2004). Our KIR typing is
validated three times a year by the International KIR Ex-
change Program organized by the Immunogenetics Center of
the University of California at Los Angeles.
HLA-C gene fragments determining the HLA-C1 and C2
groups were distinguished according to a PCR-SSP method
described by Frohn et al. (1998). HLA-Bw4 and HLA-Bw6
alleles were genotyped as described in Supplement 1.
Statistical analysis
The proportion of individuals positive for a given KIR gene as
well asHLA-C1 andC2 groups andHLA-Bw4was established
by direct counting. KIR gene frequencies (gf) were estimated
using the formula gf=1−√(1−pf), where pf is the proportion
of the population positive for the gene. Odds ratio and its 95%
confidence interval were used as a measure of effect size.
Generalized linear models with binomial errors and the chi-
square test for trend were used to investigate the relationship
between clinical and genetic variables. Akaike’s information
criterion was used as a measure of fit of models. Confidence
intervals were estimated with the bootstrap approach. P
values were computed exactly by numerical simulations.
Measures for the estimation of linkage disequilibrium (LD)
were the correlation of two alleles’ frequencies, r, global
squared correlation between two loci, R2 and Kullback-
Leibler divergence of two loci from LE (Excoffier and Slatkin
1995; Abdallah et al. 2003). For the two loci 2DS4 and 2DS5,
r and R2 were obtained as: r ¼ Di jﬃﬃﬃﬃﬃﬃpiq jp , where pi and qj are the
population allele frequencies of the ith allele on locus 2DS4
and the jth allele on locus 2DS5, Dij=xij−piqj, and xij is the
frequency of the haplotype with alleles i and j on loci 2DS4




divergence (Bhasi et al. 2006; Liu and Lin 2005), DKL is a
measure of distance between the observed haplotype distribu-






: The chi-square statistic was calculated to test
whether all of the Dij’s between 2DS4 and 2DS5 are zeros:





The frequencies of KIR genes in patients were similar to the
frequencies observed in control women (Table 1) except for
KIR2DS5. This latter result has already been described, but
without analysis of other KIR genes (Nowak et al. 2010). The
presence of KIR2DS5 significantly decreased the risk of en-
dometriosis. The KIR2DS5 effect was independent from other
KIR genes, including KIR2DS4 (P=0.181). However, it was
seen only in HLA-C C2-positive individuals: in this group,
those who possessed KIR2DS5 had 2.5 lower chance of get-
ting endometriosis than KIR2DS5-negative women
(Supplement 2). In contrast, KIR2DS5 presence did not affect
the risk of disease in C2-negative individuals (Supplement 2).
Noteworthy, C2 presence or absence itself had no relation to
disease risk (P=0.363). Similarly, there was no correlation of
HLA-Bw4 or HLA-Bw6 with disease (data not shown).
We also analyzed the genetics of peritoneal versus ovarian
endometriosis (Table 2). KIR2DS5-positive, KIR2DS4del-
negative women with endometriosis had 13 times lower
chance that the disease would occupy the peritoneum than
KIR2DS5- and KIR2DS4del-negative ones (OR=0.077, P=
0.0061). The percentage of individuals with peritoneal
Table 1 KIR gene frequencies in patients and controls
Group KIR gene
2DL1 2DL2 2DS3 2DL3 2DS2 3DL1 3DS1 2DL5 2DS1 2DS4fl 2DS4del 2DS4 2DS5
Patients, N 147 89 61 135 91 147 51 79 60 51 125 147 33*
gfa 80.3 35.3 22.5 65.6 36.4 80.3 18.3 30.4 22.0 18.3 57.2 80.3 11.5
Controls, N 205 115 70 188 116 201 85 113 94 61 181 201 68
gf 80.5 32.2 18.1 65.8 32.5 76.3 22.5 31.4 25.2 15.5 61.3 76.3 17.5
OR 0.96 1.19 1.35 1.0 1.23 1.46 0.75 0.94 0.82 1.25 0.79 1.46 0.58
N number of cases, p probability, OR odds ratio, 95 % CI confidence interval
Patients vs controls, *P=0.033, 95 % CI=0.36–0.95
a gf, gene frequency calculated according to the formula gf=1−√(1−pf)
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endometriosis in KIR2DS5-positive, KIR2DS4del-negative
persons was only 25 % in comparison to 81 % in the
double-negative group. Similarly, KIR2DS5-negative,
KIR2DS4del-positive, endometriotic persons had lower (al-
most 11 times) chance for peritoneal disease in relation to
double negative ones (OR=0.094, P<0.001). Interestingly,
although double positive (KIR2DS5+, KIR2DS4del+) geno-
type had also a decreased chance of peritoneal endometriosis,
in this case the protective effect was weaker (Table 2): this
form of disease was present in nearly 43 % of patients with
this genotype. KIR2DS4-full-length gene presence was not
related to severity of disease (data not shown). KIR2DS5
and KIR2DS4 genes are in a strong negative linkage dis-
equilibrium, as reflected by a complete lack of haplotype
positive both for KIR2DS5 and KIR2DS4del (more fre-
quent variant of KIR2DS4) in the control group
(Table 3). This haplotype is also absent from women with
ovarian endometriosis, but present in 4 % of patients with
peritoneal form of disease (Table 3).
Last but not least, the severity of disease seemed to be
associated with the KIR2DS4del gene, as the frequency of
KIR2DS4del was increased in higher disease stages
(Table 4). No other genes had any effect on the severity of
endometriosis (data not shown).
Discussion
Endometriosis is an enigmatic disease, in which many fac-
tors—genetic (Montgomery et al. 2008), neuroendocrine
(Tariverdian et al. 2007), immunological (Tariverdian et al.
2007; Matarese et al. 2003)—are involved in the pathogene-
sis. The most accepted Btransplantation theory^ (Sampson
1927) explains the presence of the majority of endometriotic
lesions in the peritoneal cavity by insufficient immune surveil-
lance. Retrograde menstruation happens in up to 90 % of
women in reproductive age. However, only minority of these
women develop endometriosis. Therefore, it is generally ac-
cepted that changes in the activity of immune cells in the
peritoneal microenvironment play an important role in the
etiology of this disease (Berkkanoglu and Arici 2003;
Matarese et al. 2003; Dmowski and Braun 2004; Ulukus
Table 2 Chance of peritoneal endometriosis depending on KIR2DS5/2DS4del genotype
2DS5 2DS4del Peritoneum Number Percent OR 95 % CI P value
+ −
− − 13 3 16 81.25 1 – – –
+ + 9 12 21 42.86 0.173 0.038 0.795 0.041
+ − 3 9 12 25.00 0.077 0.012 0.478 0.0061
− + 30 74 104 28.85 0.094 0.025 0.356 <0.001
Two-sided Fisher’s exact test was used to estimate differences between patients with peritoneal and non-peritoneal endometriosis
N number of cases with relevant genotype, p probability, OR odds ratio, 95 % CI confidence interval
Table 3 Linkage disequilibrium between two loci: KIR2DS4 and KIR2DS5
Group Haplotypes 2DS4full/2DS5 2DS4del/2DS5 ―/2DS5 2DS4full/― 2DS4del/― ―/―
Controls HFs 0.0019 0 0.1724 0.153 0.6172 0.0555




Peritoneum+ HFs 0 0.0422 0.0867 0.1976 0.5245 0.149




Peritoneum− HFs 0.0044 0 0.1077 0.15 0.6707 0.0671




HFs haplotype frequencies, DKL Kullback-Leibler divergence from linkage equilibrium, R
2 global squared correlation coefficient for two loci, r
correlation coefficient for allele frequencies, ― lack of a given gene (KIR2DS4 and/or KIR2DS5), Peritoneum+ and Peritoneum−, the presence or
absence of peritoneal endometriosis
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et al. 2006). Particularly, it has been shown that NK cells of
peripheral blood and peritoneal fluid of endometriotic patients
exhibit decreased cytotoxicity to autologous endometrium
(Oosterlynck et al. 1991; 1992). This impaired activity also
correlated with severity of the disease. Moreover, Japanese
scientists found an increased percentage of KIR2DL1-
positive NK cells in peritoneal fluid and peripheral blood of
women with pelvic endometriosis, which suggests stronger
inhibition of NK cell activity against ectopic endometrium
(Maeda et al. 2002). Individual NK cells differ in their KIR
repertoire because this results from stochastic KIR expression
in individual clones (Parham 2005). Nevertheless, a high de-
gree of genotypic polymorphism (i.e., the presence or absence
of particular KIR genes in the genotype of a given individual)
allows NK cells to express only those KIR genes which are
present in their genotype. Therefore, we looked for possible
associations ofKIR genes with susceptibility to endometriosis,
localization of lesions (ovarian versus peritoneal), and severity
of the disease.
We previously described decreased frequency of KIR2DS5
in patients with endometriosis in comparison to healthy con-
trol (Nowak et al. 2010) but other KIR genes were not ana-
lyzed there. Here, we report the protective effect of KIR2DS5
only in females who possessed the HLA-C C2 group. The
KIR2DS5 gene has been proven to be expressed at both the
mRNA (Della Chiesa et al. 2008) and protein (Steiner et al.
2014) level, although it has been reported that its transcript
could be detected in only 10 % of individuals positively ge-
notyped for this gene (Leung et al. 2005), and protein expres-
sion of different alleles varies (Steiner et al. 2014). However,
analysis of KIR expression at the protein level is difficult
because of cross-reactivity of available antibodies, especially
between inhibitory and activating receptors, which frequently
have very similar amino acid sequences in their extracellular
domains. Recently, it has been shown that monoclonal anti-
bodies 143211 and HPMA4, which were previously thought
to be specific exclusively for KIR2DL1 and KIR2DS1/L1,
respectively, also bind KIR2DS5 (143211) or KIR2DS5 and
KIR2DS3 (HPMA4) (Czaja et al. 2014). Therefore, studies
showing increased expression of KIR2DL1 but not other
KIRs in women with pelvic endometriosis (Maeda et al.
2002) should be treated with caution.
A physiologic ligand for KIR2DS5 is unknown (Parham
et al. 2012). However, circumstantial evidence suggests that it
may interact with both C1 and C2, because, in hematopoietic
stem cell transplantation, leukemia-free survival and relapse
rate depended on the presence or absence of the donor
KIR2DS5 gene as well as on the C1/C2 versus C1/C1 or C2/
C2 genotype of the recipient (van der Meer et al. 2008). Our
finding, mentioned above, also suggests an interaction be-
tween KIR2DS5 and HLA-C molecules, influencing the abil-
ity of KIR2DS5+ NK cells to eliminate ectopic endometrium
in C2+ women. Interestingly, KIR2DS5 was found protective
against another gynecological disorder, pre-eclampsia, in Brit-
ish Europeans and Ugandan Africans, and fetal C2 inherited
from the father increased the risk of disease in KIR2DS5-neg-
ative women (Nakimuli et al. 2015). However, only one allele,
KIR2DS5*006, was protective in Ugandans, and this allele is
absent from European populations, possessing only
KIR2DS5*002 if any (Hou et al. 2009; Gonzalez-Galarza
et al. 2015). Therefore, it might be that different KIR2DS5
alleles affect pre-eclampsia and endometriosis.
Moreover, we observed preferential non-peritoneal locali-
zation of lesions in patients possessing either the KIR2DS5 or
KIR2DS4del gene, whereas simultaneous presence of both
genes had a weaker effect. Interaction between these two
genes has also been found recently in renal transplantation,
where we detected a protective effect of the KIR2DS5 gene
against acute graft rejection, but only in the absence of
KIR2DS4del (Nowak et al. 2012). Interestingly, the effect of
the KIR2DS4-full-length gene on the graft protection associ-
ated with KIR2DS5 was opposite, i.e., KIR2DS5 was protec-
tive only if KIR2DS4 full-length was present (Nowak et al.
2012). Here, we observed a much lower percentage of perito-
neal endometriosis in women possessing either the KIR2DS5
or KIR2DS4del gene than when both were present. Moreover,
even in the subgroup of KIR2DS5+/KIR2DS4del+ patients,
the fraction with peritoneal lesions was twice as low as in
women negative for both these genes. However, the numbers
were too small to draw a firm conclusion.
KIR2DS5 and KIR2DS4 genes are in strong negative
linkage disequilibrium in our population (Table 3 and
Niepiekło-Miniewska et al. 2013), and KIR2DS4del and
KIR2DS4-full-length are alleles. Therefore, individuals pos-
itive for KIR2DS5 and KIR2DS4del are highly unlikely to
possess KIR2DS4-full-length; similarly, individuals positive
for KIR2DS5 and KIR2DS4-full-length are highly unlikely
to be KIR2DS4del-positive. In peritoneal endometriosis,
we observed only a weak effect of KIR2DS4del on
KIR2DS5 association with lack of endometrial lesions in
the peritoneum, and no effect of KIR2DS4-full-length.




2DS4del− 5 9 6
2DS4del+ 7 33 49
% 58.33 78.57 89.09
P 0.012
The chi-square test for trend was used to investigate the relationship
between clinical and genetic variables
p probability, I+II minimal and mild endometriosis, III moderate,
IV severe
Immunogenetics (2015) 67:203–209 207
KIR2DS4-full-length variant and KIR2DS5 had frequencies
of only 18.3 and 11.5 % in our patients, respectively, so
the number of women with peritoneal endometriosis (N=
55) was perhaps too small to detect the interaction of
KIR2DS4-full-length with KIR2DS5 similar to that ob-
served in kidney graft rejection.
Patients with endometriotic lesions limited to the peritone-
um belong to a group of mild severity of this disease. NK cells
may have the potential to remove endometriotic tissues from
the peritoneal cavity but may not have such easy access to
ovarian cysts, which are associated with more severe manifes-
tation of endometriosis. Associations of KIR2S5 and
KIR2DS4del with protection from peritoneal but not ovarian
lesions in endometriotic patients suggest that peritoneal endo-
metriosis may have a different genetic background than ovarian
endometriosis. Indeed, the same KIR2DS4del which was asso-
ciated with protection from peritoneal lesions was associated
with the highest grades of endometriosis which encompass
ovarian lesions.
The only report on KIR gene associations with endometri-
osis published so far in addition to our KIR2DS5 paper
(Nowak et al. 2010) is that by Kitawaki et al. (2007), who
described decreased frequency ofKIR3DS1 and increased fre-
quency of highly inhibitory KIR-HLA combinations. This
result is somewhat similar to ours, because KIR haplotypes
consisting mostly of inhibitory KIR genes (called A haplo-
types) are lacking KIR2DS5 although not KIR2DS4 (Jiang
et al. 2012). In addition, we also observed slightly decreased
presence ofKIR3DS1 in patients with endometriosis but it was
not significant. The Japanese population demonstrates differ-
ent KIR gene distribution from Europeans (allele frequency
net: Gonzalez-Galarza et al. 2015), and is particularly rich in
A haplotype homozygotes (Hiby et al. 2004).
In conclusion,
(i) The presence of KIR2DS5 reduced the risk of disease if
a female possessed alleles from group C2 of HLA-C.
(ii) In endometriotic patients, KIR2DS5 or KIR2DS4del
presence lowered the risk of localization of lesions in
the peritoneum.
(iii) On the other hand, KIR2DS4del presence in patients
was associated with severity of endometriosis, which,
due to strong negative LD, may suggest an indirect ef-
fect of KIR2DS5 absence.
(iv) Our results suggest a different genetic background of
peritoneal and ovarian endometriosis.
Zhang et al. (2006) proposed KIR and HLA expres-
sion studies as an immunodiagnostic parameter for pel-
vic endometriosis. We believe that our results may sup-
port their proposal and extend it to genotyping patients
for KIR2DS4 and KIR2DS5, as well as for HLA-C C1
and C2.
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